Abstract
Body image disturbance (BID) is a diagnostic feature of anorexia nervosa (AN), with few reliable visual perceptual or attitudinal markers. Somatomap is a 2-dimensional (2D) and 3-dimensional (3D) digital assessment of BID, which has demonstrated utility. Test-retest reliability of Somatomap 2D and 3D digital assessment of BID in AN was examined. Fifty-nine inpatient participants with AN performed test-retest by a) outlining body concern areas on a 2D avatar for each independent area of concern; and b) sculpting 23 independent body parts on a randomized 3D avatar to reflect their perceived body size in length and girth. Participants corresponding body parts were physically measured to calculate discrepancy scores (i.e., 3D perceived minus measured values). Regional 2D BID test-retest differences were evaluated using z-scores to generate statistical visual body maps. Test-retest of 3D assessment reliability was evaluated by Intraclass Correlation Coefficient for individual and aggregated body parts. Somatomap 2D demonstrated excellent test-retest reliability with no statistical differences between test and retest z-scores. All 23 body parts on Somatomap 3D demonstrated statistically significant fair-to-excellent test-retest reliability in AN. Regions that are commonly of concern in AN, and combined measures, showed the highest reliability. Results suggest that Somatomap 2D and 3D may provide a reliable perceptual marker of visual BID in AN.
Competing Interest Statement
A.C.A. is founder of Insight Health Systems, Arevian Technologies, and Open Science Initiative. A.C.A. developed the Chorus platform, which is licensed from the University of California Los Angeles to Insight Health Systems.
Funding Statement
This work was supported by The William K. Warren Foundation (SSK). Additional support included NIMH R01MH093676-02S1 (A.C.A.), NIMH K23MH112949 (SSK), NIGMS P20GM121312 (SSK), NIMH R01MH105662-03S1 (JDF), and personal development funding (CRN).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Western Institutional Review Board gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
This is the correct preprint.
Data Availability
All data produced in the present study may be obtained by writing first author with reasonable request.